Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 10 citing Rosenfeld: Intravitreal Avastin for choroidal neovascularisation in pathological myopia:.... (0.22 sec) 

Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to …

- prsjournal.com [PDF] 
L Arias, N Planas, S Prades, JM Caminal, M … - British Medical Journal, 2008 - bjo.bmj.com
Results: There were 17 eyes of 17 patients, and the mean age was 55.4 (SD 10.0)
years. At the 6-month follow-up, the mean visual acuity improved by 8.4 letters
(p = 0.04). Forty-one per cent of patients increased at least one line, and ...
Cited by 16 - Related articles - All 5 versions

Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal …

- prsjournal.com
RM Silva, JM Ruiz-Moreno, J Nascimento, A … - Retina, 2008 - pdfs.journals.lww.com
A significant reduction in ocular coherence tomography central thickness was
observed at 1, 3, and 6 months. No cases of severe visual acuity loss occurred,
and no systemic or ocular side effects were registered during the ...
Cited by 13 - Related articles - All 5 versions

Intravitreal ranibizumab (Lucentis®) for the treatment of myopic choroidal neovascularization


L Konstantinidis, I Mantel, JAC Pournaras, L … - Graefe's Archive for Clinical and Experimental …, 2009 - Springer
Abstract Background Macular choroidal neovascularization (CNV) is one of the
most vision-threatening complications of myopia, which can lead to severe vision
loss. The purpose of this study was to evaluate the safety and efficacy of ...
Cited by 6 - Related articles - All 2 versions

Avastin in myopic choroidal neovascularisation: is age the limit?

- prsjournal.com
D Wong, KKW Li - British Journal of Ophthalmology, 2008 - bjo.bmj.com
There are a growing number of publications supporting the use of Avastin
(bevacizumab) for choroidal neovascularisation (CNV) secondary to pathological
myopia (table 1).1 – 8 In this issue, Arias et al (see page 1035) ...
Cited by 1 - Related articles - All 4 versions

Intravitreal Bevacizumab bei choroidaler Neovaskularisation infolge pathologischer Myopie


S Dithmar, KB Schaal, AE Höh, S Schmidt, F … - Der Ophthalmologe, 2009 - Springer
DerVortrag wurde auf der 105. Jahrestagung der DOG gehalten. ... Ophthalmologe
2009 · 106:527–530 DOI 10.1007/s00347-008-1806-z Online publiziert: 9. August
2008 © Springer Medizin Verlag 2008 ... S. Dithmar · KB Schaal · AE ...
Cited by 1 - Related articles

Anti-Vegf Drugs As the 2009 First-Line Therapy for Choroidal Neovascularization in …

- duanessolution.com
SY COHEN - Retina, 2009 - journals.lww.com
Choroidal neovascularization (CNV) is the com- mon cause of visual loss in
pathologic myopia. Among patients younger than 50 years, myopia ac- counted for
62% of cases of CNV.1 The natural his- tory of myopic subfoveal CNV has ...
Related articles - All 3 versions

Verteporfin photodynamic therapy in the age of antiangiogenic therapy


IA Barbazetto, BS Takahashi - Expert Review of Ophthalmology, 2008 - ingentaconnect.com
Photodynamic therapy with verteporfin was the first approved pharmacological
treatment for choroidal neovascularization in patients with age-related macular
degeneration, pathologic myopia and ocular histoplasmosis syndrome. With ...
Related articles - All 3 versions

Photodynamic therapy with verteporfin in choroidal neovascularization after refractive …


P Amat-Peral, F Lugo, JA Montero, C De-La- … - Archivos de la Sociedad Española de Oftalmología, 2008 - SciELO Brasil
Related articles - Cached - All 4 versions

[PDF] TERAPIA FOTODINÁMICA CON VERTEPORFINA EN NEOVASCULARIZACIÓN COROIDEA …


CNA REFRACTIVE - ARCH SOC ESP OFTALMOL, 2008 - SciELO Espana
Recibido: 27/2/07. Aceptado: 25/8/08. Instituto Oftalmológico de
Alicante-Vissum. Alicante. España. Clínica Oftalmológica Centro Caracas.
Caracas. Valenzuela. 1 Licenciado en Medicina. Instituto Oftalmológico de ...
Related articles - View as HTML - All 3 versions

PHOTODYNAMIC THERAPY WITH VERTEPORFIN IN CHOROIDAL …


TFCONVEN NEOVASCULARIZACIÓN, … - oftalmo.com
Propósito Analizar los resultados obtenidos usando TFD (terapia fotodinámica)
con verteporfina como primera elección para tratar la NVC (neovascularización
coroidea) subfoveal y yuxtafoveal en pacientes con miopía magna corregida ...
Related articles - Cached


 


Go to Google Home - About Google - About Google Scholar

©2009 Google